TickerFacts.

Genelux Corp (GNLX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$11.54M
As of 2025-12-31
$16.11M
As of 2026-06-30
$26.27M2022-12-31: -$35.78M2023-12-31: $19.47M2024-12-31: $26.27M2025-12-31: $11.54M$11.54M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$11.54M-56.1%2026-03-19, Balance as of period end
2024-12-31$26.27M+34.9%2026-03-19, Balance as of period end
2023-12-31$19.47Mn/m2025-03-28, Balance as of period end
2022-12-31-$35.78Mn/a2024-03-29, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Genelux Corp (GNLX)2025-12-31$11.54M-56.1%
Aspire-Lakewood Holdings, Inc. (ASBP)2025-12-31-$6.38Mn/m
Alaunos Therapeutics, Inc. (TCRT)2025-12-31$2.15M+4.4%
One World Products, Inc. (OWPC)2024-12-31-$9.91Mn/m
PRF Technologies Ltd. (PRFX)2025-12-31$8.54M+368.4%
Bioadaptives, Inc. (BDPT)2025-12-31-$2.13Mn/m
Skinvisible, Inc. (SKVI)2025-12-31-$10.26Mn/m
Aditxt, Inc. (ADTX)2025-12-31$5.61M+235.0%
Jupiter Neurosciences, Inc. (JUNS)2025-12-31-$1.83Mn/m

Compare GNLX, ASBP, TCRT, OWPC side by side · Screen every company in Pharmaceutical Preparations ↗